Advertisement
Advertisement

ZURA

ZURA logo

Zura Bio Limited Class A Ordinary Shares

5.96
USD
Sponsored
+0.25
+4.47%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

6.00

+0.04
+0.60%

Zura Bio Limited Class A Ordinary Shares Profile

About

Zura Bio Limited is a clinical-stage biotechnology company advancing primary assets, including ZB-168 in Alopecia Areata and other inflammatory diseases and torudokimab in both chronic obstructive pulmonary disease and asthma. Zura Bio Limited, formerly known as JATT Acquisition Corp, is headquartered in London, UK.

Info & Links

CEO

Sandeep Kulkarni

Headquarters

1489 W. Warm Springs Road, Suite 110
Henderson, NV 89014, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://zurabio.com

Auditor

WithumSmith+Brown, PC

Share holders

12

Employees

40

Zura Bio Limited Class A Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

570.08M

Enterprise Value

344.49M

Enterprise Value/EBITDA(ttm)

-4.23

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.61

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-55.74%

Return on Invested Capital(ttm)

-57.06%

Return on Assets(ttm)

-48.07%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-81.44M

Net Income Available to Common(ttm)

-106.13M

Diluted EPS(ttm)

-1.09

Share Statistics

Beta (5Y Monthly)

-0.02

52-Week Change

303.04%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

95.00M

Dividend Yield

0.00%

Float4

83.14M

% Held by Insiders

12.37%

% Held by Institutions

61.14%

Balance Sheet

Total Cash(mrq)

225.59M

Total Cash Per Share(mrq)

2.37

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

19.33%

Quick Ratio(mrq)

19.33%

Book Value Per Share(mrq)

2.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.17

Free Cash Flow(ytd)

-18.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement